Patents by Inventor Srinivas Reddy DESI REDDY

Srinivas Reddy DESI REDDY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical polymorphs of Molnupiravir
    Patent number: 11702440
    Abstract: The present invention provides a crystalline and an amorphous form of a Molnupiravir and methods of making the crystalline form and amorphous form of Molnupiravir.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: July 18, 2023
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Subba Reddy Peketi
  • NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE
    Publication number: 20230122169
    Abstract: The present invention relates to a crystal form of (?)-Cibenzoline succinate. In addition, the present invention relates to a method for preparing (?)-Cibenzoline succinate having a chiral purity of 99.9% or higher. Additionally, the present invention provides a method for preparing (?)-Cibenzoline succinate and a crystal form thereof.
    Type: Application
    Filed: September 29, 2019
    Publication date: April 20, 2023
    Inventors: Srinivas Reddy Desi Reddy, Vijayavitthal Thippannachar Mathad, Dnyandev Ragho Rane, Vikas Shivaji Patil
  • PHARMACEUTICAL POLYMORPHS OF MOLNUPIRAVIR
    Publication number: 20220185840
    Abstract: The present invention provides a crystalline and an amorphous form of a Molnupiravir and methods of making the crystalline form and amorphous form of Molnupiravir.
    Type: Application
    Filed: August 18, 2021
    Publication date: June 16, 2022
    Applicant: OPTIMUS DRUGS (P) LTD
    Inventors: Srinivas Reddy DESI REDDY, Subba Reddy PEKETI
  • Process for molnupiravir
    Patent number: 11312743
    Abstract: The present invention relates to a process for the preparation of Molnupiravir. The present invention also relates to an improved and commercially viable process for preparation of Molnupiravir with high yield and purity.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: April 26, 2022
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Subba Reddy Peketi, Venkata Gnaneswara Rao Guttikonda, Siva Reddy Desi Reddy
  • Process for the preparation of Canagliflozin
    Patent number: 10370365
    Abstract: The present invention provides a novel process for the preparation of Canagliflozin (I) and its hydrates thereof by employing novel intermediates. The present invention is also provides commercially and industrial applicable process.
    Type: Grant
    Filed: August 23, 2016
    Date of Patent: August 6, 2019
    Assignee: OPTIMUS DRUGS (P) LIMITED
    Inventors: Srinivas Reddy Desi Reddy, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela
  • Process for the preparation of sofosbuvir
    Patent number: 10239910
    Abstract: The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of sofosbuvir, which uses reagents that are less expensive and easier to handle.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: March 26, 2019
    Assignee: OPTIMUS DRUGS (P) LIMITED
    Inventors: Srinivas Reddy Desi Reddy, Srinivas Rao Velivela
  • Process for the preparation of Ledipasvir
    Patent number: 10118912
    Abstract: An improved process is provided for the preparation of Ledipasvir and its pharmaceutically acceptable salts or solvates thereof, which is useful as an antiviral agent. This disclosure also provides a process for the preparation of key intermediates of Ledipasvir.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: November 6, 2018
    Assignee: Optimus Drugs Private Ltd.
    Inventors: Dnyandev Ragho Rane, Srinivas Reddy Desi Reddy, Subbareddy Peketi, Srinivas Rao Velivela
  • Process for the preparation of Apixaban
    Patent number: 10077263
    Abstract: The present invention relates to an improved process for the preparation of Apixaban and its intermediates.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: September 18, 2018
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela
  • PROCESS FOR THE PREPARATION OF SOFOSBUVIR
    Publication number: 20180022774
    Abstract: The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of sofosbuvir, which uses reagents that are less expensive and easier to handle.
    Type: Application
    Filed: May 8, 2017
    Publication date: January 25, 2018
    Inventors: Srinivas Reddy Desi Reddy, Srinivas Rao Velivela
  • PROCESS FOR THE PREPARATION OF APIXABAN
    Publication number: 20170313695
    Abstract: The present invention relates to an improved process for the preparation of Apixaban and its intermediates.
    Type: Application
    Filed: July 28, 2016
    Publication date: November 2, 2017
    Inventors: Srinivas Reddy DESI REDDY, Dnyandev Ragho RANE, Venkata Srinivaso Rao VELIVELA
  • PROCESS FOR THE PREPARATION OF LEDIPASVIR
    Publication number: 20170197944
    Abstract: An improved process is provided for the preparation of Ledipasvir and its pharmaceutically acceptable salts or solvates thereof, which is useful as an antiviral agent. This disclosure also provides a process for the preparation of key intermediates of Ledipasvir.
    Type: Application
    Filed: June 29, 2016
    Publication date: July 13, 2017
    Applicant: Optimus Drugs, LLC
    Inventors: Srinivas Reddy Desi Reddy, Subbareddy Peketi, Dnyandev Ragho Rane, Srinivas Rao Velivela
  • Industrial process for making an Ivacaftor and its intermediates
    Patent number: 9676722
    Abstract: The present invention relates to an improved process for the preparation of Ivacaftor intermediates. The present invention is also provides industrial applicable, commercially and eco-friendly viable process for the preparation of Ivacaftor.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: June 13, 2017
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela
  • Process for the preparation of linezolid
    Patent number: 9643939
    Abstract: The present invention relates to an improved process for the preparation of Linezolid. More specifically, the present invention relates to an improved process for preparing (S)—N-[[3-[3-fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl] phthalimide and (S)-glycidyl phthalimide intermediates, which are used in the preparation of Linezolid.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: May 9, 2017
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Subba Reddy Peketi, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela
  • Industrial Process for Making an Ivacaftor and its Intermediates
    Publication number: 20170096397
    Abstract: The present invention relates to an improved process for the preparation of Ivacaftor intermediates.
    Type: Application
    Filed: August 24, 2016
    Publication date: April 6, 2017
    Inventors: Srinivas Reddy Desi Reddy, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela
  • NOVEL PROCESS FOR THE PREPARATION OF CANAGLIFLOZIN
    Publication number: 20170073336
    Abstract: The present invention provides a novel process for the preparation of Canagliflozin (I) and its hydrates thereof by employing novel intermediates. The present invention is also provides commercially and industrial applicable process.
    Type: Application
    Filed: August 23, 2016
    Publication date: March 16, 2017
    Inventors: Srinivas Reddy DESI REDDY, Dnyandev Ragho RANE, Venkata Srinivasa Rao VELIVELA
  • Process for the preparation of linezolid
    Patent number: RE47606
    Abstract: The present invention relates to an improved process for the preparation of Linezolid. More specifically, the present invention relates to an improved process for preparing (S)—N-[[3-[3-fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl] phthalimide and (S)-glycidyl phthalimide intermediates, which are used in the preparation of Linezolid.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: September 17, 2019
    Assignee: OPTIMUS DRUGS PRIVATE LIMITED
    Inventors: Srinivas Reddy Desi Reddy, Subba Reddy Peketi, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela